TD2, a leading oncology CRO, advances oncology research by guiding new oncology therapies from preclinical and clinical trial phases to FDA approval.

Choosing TD2 means selecting a dedicated partner that combines scientific rigor with strategic vision. Our comprehensive oncology ecosystem and collaborative approach ensure your drug …

TD2 Oncology accelerates preclinical drug development with a robust suite of in vivo and in vitro tumor model systems and advanced bioanalytical services, designed to generate clinically …

TD2 has provided several incredible opportunities that have allowed me to utilize my previous experience in clinical research to help drive positive, meaningful decisions that benefit our …

Jun 4, 2020 · TD2, based in Scottsdale, Arizona, focuses exclusively on oncology medicine development with unparalleled experience conducting translational studies from bench-to …

HAVE A QUESTION? Contact Our Experts GET STARTED Ask us how you can get your oncology medicine to market faster with TD2. Get Started Now

Jul 29, 2025 · The partnership combines TD2’s proven oncology execution capabilities with Curadh’s deep scientific innovation in the radiopharmaceutical space, accelerating the …

Jul 29, 2025 · TGen Drug Development (TD2) and Imaging Endpoints have teamed up to enable the rapid development of anti-cancer drugs and deliver them faster to patients in need, the …

At TD2 Oncology, we provide comprehensive clinical research solutions tailored specifically for oncology. From trial design and feasibility through site management, data analysis, and final …

Sep 4, 2024 · TD2 continues to be a trusted partner in the pharmaceutical and biotech industry, offering a wide range of services, including preclinical and clinical trial management, …